National Institute for Occupational Safety and Health; Designation of a Class of Employees for Addition to the Special Exposure Cohort, 9536 [07-948]
Download as PDF
9536
Federal Register / Vol. 72, No. 41 / Friday, March 2, 2007 / Notices
pwalker on PROD1PC71 with NOTICES
The agenda will focus on the
oversight of genetic testing, including
the role of the private sector in assuring
the quality and validity of genetic tests;
the impact of gene patents and licensing
practices on patient access to genetic
technologies, including a progress
report on the Committee’s study; and
the status of Federal genetic information
nondiscrimination legislation. The
Committee will be briefed on the
Secretary’s Personalized Health Care
Initiative and the work of the American
Health Information Community,
particularly its Personalized Health Care
Working Group. The Committee’s report
on the Policy Issues Associated with
Undertaking a New Large U.S.
Population Cohort Project on Genes,
Environment and Disease will be
released at the meeting. There also will
be updates on the Committee’s draft
report on pharmacogenomics and
several Federal initiatives and activities.
Time will be provided each day for
public comments. The Committee
would welcome hearing from anyone
wishing to provide public comment on
any issue related to genetics, health and
society. Individuals who would like to
provide public comment should notify
the SACGHS Executive Secretary, Ms.
Sarah Carr, by telephone at 301–496–
9838 or e-mail at sc112c@nih.gov. The
SACGHS office is located at 6705
Rockledge Drive, Suite 750, Bethesda,
MD 20892. Anyone planning to attend
the meeting, who is in need of special
assistance, such as sign language
interpretation or other reasonable
accommodations, is also asked to
contact the Executive Secretary.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
and genomic technologies and, as
warranted, to provide advice on these
issues. The draft meeting agenda and
other information about SACGHS,
including information about access to
the Web cast, will be available at the
following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
Dated: February 22, 2007.
Anna Snouffer,
Acting Director, NIH Office of Federal
Advisory Committee Policy.
[FR Doc. 07–973 Filed 3–1–07; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
18:44 Mar 01, 2007
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute for Occupational
Safety and Health; Designation of a
Class of Employees for Addition to the
Special Exposure Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) gives notice of a
decision to designate a class of
employees at General Atomics in La
Jolla, California, as an addition to the
Special Exposure Cohort (SEC) under
the Energy Employees Occupational
Illness Compensation Program Act of
2000. On February 16, 2007, the
Secretary of HHS designated the
following class of employees as an
addition to the SEC:
Atomic Weapons Employer (AWE)
employees who were monitored or should
have been monitored for exposure to ionizing
radiation while working at the General
Atomics facility in La Jolla, California at the
following locations: Science Laboratories A,
B, and C (Building 2); Experimental Building
(Building 9); Maintenance (Building 10);
Service Building (Building 11); Buildings 21
and 22; Hot Cell Facility (Building 23); Waste
Yard (Buildings 25 and 26); Experimental
Area (Buildings 27 and 27–1); LINAC
Complex (Building 30); HTGR–TCF (Building
31); Fusion Building (Building 33); Fusion
Doublet III (Building 34); SV–A (Building
37); SV–B (Building 39); and SV–D (no
building number) for a number of work days
aggregating at least 250 work days from
January 1, 1960, through December 31, 1969,
or in combination with work days within the
parameters established for one or more other
classes of employees in the Special Exposure
Cohort.
This designation will become
effective on March 18, 2007, unless
Congress provides otherwise prior to the
effective date. After this effective date,
HHS will publish a notice in the
Federal Register reporting the addition
of this class to the SEC or the result of
any provision by Congress regarding the
decision by HHS to add the class to the
SEC.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 513–
533–6800 (this is not a toll-free
number). Information requests can also
be submitted by e-mail to
OCAS@CDC.GOV.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Dated: February 23, 2007.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 07–948 Filed 3–1–07; 8:45 am]
BILLING CODE 4160–17–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute for Occupational
Safety and Health; Designation of a
Class of Employees for Addition to the
Special Exposure Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).
AGENCY:
ACTION:
Notice.
SUMMARY: The Department of Health and
Human Services (HHS) gives notice of a
decision to designate a class of
employees at the Monsanto Chemical
Company in Dayton, Ohio, as an
addition to the Special Exposure Cohort
(SEC) under the Energy Employees
Occupational Illness Compensation
Program Act of 2000. On February 16,
2007, the Secretary of HHS designated
the following class of employees as an
addition to the SEC:
Atomic Weapons Employer (AWE)
employees who were monitored or should
have been monitored for exposure to ionizing
radiation while working at Monsanto
Chemical Company Units I, III, or IV in
Dayton, Ohio, for a number of work days
aggregating at least 250 work days during the
period from January 1, 1943, through
December 31, 1949, or in combination with
work days within the parameters established
for one or more other classes of employees
in the Special Exposure Cohort.
This designation will become
effective on March 18, 2007, unless
Congress provides otherwise prior to the
effective date. After this effective date,
HHS will publish a notice in the
Federal Register reporting the addition
of this class to the SEC or the result of
any provision by Congress regarding the
decision by HHS to add the class to the
SEC.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 513–
533–6800 (this is not a toll-free
number). Information requests can also
be submitted by e-mail to
OCAS@CDC.GOV.
E:\FR\FM\02MRN1.SGM
02MRN1
Agencies
[Federal Register Volume 72, Number 41 (Friday, March 2, 2007)]
[Notices]
[Page 9536]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-948]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute for Occupational Safety and Health;
Designation of a Class of Employees for Addition to the Special
Exposure Cohort
AGENCY: National Institute for Occupational Safety and Health (NIOSH),
Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) gives notice
of a decision to designate a class of employees at General Atomics in
La Jolla, California, as an addition to the Special Exposure Cohort
(SEC) under the Energy Employees Occupational Illness Compensation
Program Act of 2000. On February 16, 2007, the Secretary of HHS
designated the following class of employees as an addition to the SEC:
Atomic Weapons Employer (AWE) employees who were monitored or should
have been monitored for exposure to ionizing radiation while working
at the General Atomics facility in La Jolla, California at the
following locations: Science Laboratories A, B, and C (Building 2);
Experimental Building (Building 9); Maintenance (Building 10);
Service Building (Building 11); Buildings 21 and 22; Hot Cell
Facility (Building 23); Waste Yard (Buildings 25 and 26);
Experimental Area (Buildings 27 and 27-1); LINAC Complex (Building
30); HTGR-TCF (Building 31); Fusion Building (Building 33); Fusion
Doublet III (Building 34); SV-A (Building 37); SV-B (Building 39);
and SV-D (no building number) for a number of work days aggregating
at least 250 work days from January 1, 1960, through December 31,
1969, or in combination with work days within the parameters
established for one or more other classes of employees in the
Special Exposure Cohort.
This designation will become effective on March 18, 2007, unless
Congress provides otherwise prior to the effective date. After this
effective date, HHS will publish a notice in the Federal Register
reporting the addition of this class to the SEC or the result of any
provision by Congress regarding the decision by HHS to add the class to
the SEC.
FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of
Compensation Analysis and Support, National Institute for Occupational
Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46, Cincinnati,
OH 45226, Telephone 513-533-6800 (this is not a toll-free number).
Information requests can also be submitted by e-mail to OCAS@CDC.GOV.
Dated: February 23, 2007.
John Howard,
Director, National Institute for Occupational Safety and Health.
[FR Doc. 07-948 Filed 3-1-07; 8:45 am]
BILLING CODE 4160-17-M